These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 100778

  • 1. [Treatment of bronchial lesions in pulmonary tuberculosis with primary drug resistance of Mycobacteria].
    Fedotova ZN, Shesterina MV.
    Probl Tuberk; 1978 Aug; (8):31-4. PubMed ID: 100778
    [No Abstract] [Full Text] [Related]

  • 2. [Primary drug resistance of tuberculosis mycobacteria].
    Fedotova ZN, Kerpel' RS.
    Probl Tuberk; 1971 Aug; 49(11):33-7. PubMed ID: 5004856
    [No Abstract] [Full Text] [Related]

  • 3. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI, Terentieva AS.
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract] [Full Text] [Related]

  • 4. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V.
    Arch Monaldi; 1972 Dec; 27(4):454-74. PubMed ID: 4217601
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
    Zozuliak VI.
    Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
    [No Abstract] [Full Text] [Related]

  • 7. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J, Holecková R, Rozánek R, Starosta V, Strnad M, Sebests J, Strusa V.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965 Jun; 8(5):589-92. PubMed ID: 4955225
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C, Velluti G, Mantovani P.
    Arch Monaldi; 1978 Jun; 33(4):251-79. PubMed ID: 116622
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A, Krakówka P.
    Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections].
    Rowińska-Zakrzewska E, Słupek A, Graczyk J, Zwolska-Kwiek Z, Augustynowicz-Kopeć E, Stambrowska A, Byszewska D, Latoś E, Pilarska A, Andrzejczyk Z.
    Pneumonol Alergol Pol; 1992 Apr; 60(9-10):81-8. PubMed ID: 1338003
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.